The researchers built a tiny device with a spring that ejects a tiny dart of solid insulin into the wall of the stomach, said researcher Carlo Giovanni Traverso, PhD.
“We chose the stomach as the site of delivery because we recognized that the stomach is a thick and robust part of the GI tract,” Dr. Traverso said.
When the device gets into the stomach, the humidity there lets the spring launch the insulin dart.
The researchers have tested the device on pigs and found it can deliver a therapeutic dose of insulin if the pig has an empty stomach. They published their findings in Science.
They are now working with the global healthcare company Novo Nordisk to prepare the device for human testing.
More articles on clinical leadership & infection control:
13 patients harmed by care at Johns Hopkins All Children’s, system says
VA hospitals report lower death rates than non-VA facilities, USA Today finds
10 growth opportunities for precision imaging, as outlined by Frost & Sullivan
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
